- Companies
- Globus Medical
Globus Medical Valuation Multiples
Globus Medical is valued at $9.3B as of November 2026, a 2.9x revenue multiple. In the last 12 months, Globus Medical revenue was $3.1B and Globus Medical EBITDA was $1.1B.
Globus Medical Overview
About Globus Medical
Through innovative technology and M&A activity, Globus Medical transformed into the number two medical device manufacturer in the competitive spine market. The firm was founded in 2003 with a heavy focus on internal research and development but vaulted its market share in 2023 through a merger with former competitor NuVasive. In 2025, the company acquired Nevro, a smaller player that specialized in spinal cord stimulation therapy. Globus Medical reports two business segments, musculoskeletal solutions and enabling technologies, which consist of implants used in surgery and associated technologies that assist the physician.
Founded
2003
HQ
Employees
6.0K
Website
Financials (LTM)
EV
$8.9B
Valuation Multiples
Start free trialGlobus Medical Financials
Globus Medical reported last 12-month revenue of $3.1B and EBITDA of $1.1B.
In the same LTM period, Globus Medical generated $2.1B in gross profit, $1.1B in EBITDA, and $665M in net income.
Revenue (LTM)
Globus Medical P&L
In the most recent fiscal year, Globus Medical reported revenue of $2.9B and EBITDA of $875M.
Globus Medical is profitable as of last fiscal year, with gross margin of 67%, EBITDA margin of 30%, and net margin of 18%.
Financial data powered by Morningstar, Inc.
Globus Medical Stock Performance
Globus Medical has current market cap of $9.3B, and enterprise value of $8.9B.
Market Cap Evolution
Globus Medical's stock price is $69.99.
Globus Medical share price decreased by 10.3% in the last 30 days, and by 23.1% in the last year.
Globus Medical has an EPS (earnings per share) of $4.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8.9B | $9.3B | -0.7% | -10.3% | -14.0% | -23.1% | $4.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGlobus Medical Valuation Multiples
Globus Medical trades at 2.9x EV/Revenue multiple, and 8.4x EV/EBITDA.
EV / Revenue (LTM)
Globus Medical Financial Valuation Multiples
As of November 18, 2026, Globus Medical has market cap of $9.3B and EV of $8.9B.
Globus Medical has a P/E ratio of 13.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Globus Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Globus Medical Margins & Growth Rates
Globus Medical grew revenue by 5% and EBITDA by 22% in the last fiscal year.
In the most recent fiscal year, Globus Medical reported gross margin of 67%, EBITDA margin of 30%, and net margin of 18%.
Globus Medical Margins
Globus Medical Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Globus Medical Operational KPIs
Globus Medical's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Globus Medical's Rule of 40 is 40% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Globus Medical's Rule of X is 48% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Globus Medical Competitors
Globus Medical competitors include Bruker, Bio-Rad Laboratories, Insulet, Sysmex, Shimadzu, Demant, Bausch + Lomb, Getinge, Snibe and Fresenius Medical Care.
Most Globus Medical public comparables operate across Medical Devices, DeepTech and HealthTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $3.4B | $288M | 3.2x | 3.1x | 38.1x | 17.3x | |||
| $2.6B | $1.1B | 3.7x | 3.7x | 8.5x | 21.6x | |||
| $2.7B | $455M | 3.9x | 3.2x | 23.0x | 13.0x | |||
| $3.1B | $621M | 2.6x | 2.4x | 13.1x | 12.1x | |||
| $3.5B | $630M | 2.2x | 2.1x | 12.5x | 12.2x | |||
| $3.4B | $748M | 4.0x | 3.5x | 18.1x | 14.3x | |||
| $5.1B | $513M | 2.4x | 2.3x | 23.7x | 11.4x | |||
| $3.5B | $576M | 2.4x | 2.3x | 14.4x | 11.5x | |||
This data is available for Pro users. Sign up to see all Globus Medical competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by Globus Medical
Globus Medical has acquired 12 companies to date.
Last acquisition by Globus Medical was on November 3rd 2026. Globus Medical acquired Synaptive Medical for undisclosed valuation.
Latest Acquisitions by Globus Medical
| Description | Toronto-headquartered Synaptive Medical is a neurosurgery technology company developing the BrightMatter system for integrated imaging, navigation, and robotic microscopy. Its modular platforms automate microscope control and provide real-time 3D visualization during brain and spine procedures. Founded in 2012 in Ontario, Canada, the firm advances patient outcomes by streamlining operating room workflows across neurological interventions. | Higgs Boson Health is a Boston-based digital health platform providing patient engagement tools for surgical and interventional procedures. The service offers preoperative education, remote monitoring, and recovery tracking via mobile apps integrated with electronic health records at hospitals like Massachusetts General. Launched in 2020, it reduces readmissions through AI-driven personalized care plans. | Nevro is a global medical device company headquartered in Redwood City, California, that specializes in neuromodulation for chronic pain management. The firm commercializes the Senza spinal cord stimulation system, distinguished by its HF10 therapy delivering high-frequency waveforms at 10 kHz. FDA-approved for back, leg, and intractable pain, Senza treats conditions without paresthesia. Nevro serves patients through physicians in the United States, Europe, and Australia. | NuVasive is a San Diego-based medical technology company developing products for minimally invasive spine surgery. Its portfolio includes the Pulse platform integrating imaging, neuromonitoring, and implants like CoRoent XL cages and Modulus cervical plates. NuVasive serves spine surgeons globally with solutions for lumbar, cervical, and thoracolumbar procedures. Founded in 1999, the company operates in over 20 countries with manufacturing in the U.S. and Europe. | |
| HQ Country | |||||
| HQ City | Toronto | Durham, NC | San Francisco, CA | San Diego, CA | |
| Deal Date | 3 Nov 2026 | 26 Aug 2026 | 6 Feb 2025 | 9 Feb 2023 | |
| Valuation | undisclosed | undisclosed | $250M | $3.1B | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Globus Medical acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Globus Medical
| When was Globus Medical founded? | Globus Medical was founded in 2003. |
| Where is Globus Medical headquartered? | Globus Medical is headquartered in United States. |
| How many employees does Globus Medical have? | As of today, Globus Medical has over 6K employees. |
| Who is the CEO of Globus Medical? | Globus Medical's CEO is Keith W. Pfeil. |
| Is Globus Medical publicly listed? | Yes, Globus Medical is a public company listed on NYSE. |
| What is the stock symbol of Globus Medical? | Globus Medical trades under GMED ticker. |
| When did Globus Medical go public? | Globus Medical went public in 2012. |
| Who are competitors of Globus Medical? | Globus Medical main competitors include Bruker, Bio-Rad Laboratories, Insulet, Sysmex, Shimadzu, Demant, Bausch + Lomb, Getinge, Snibe, Fresenius Medical Care. |
| What is the current market cap of Globus Medical? | Globus Medical's current market cap is $9.3B. |
| What is the current revenue of Globus Medical? | Globus Medical's last 12 months revenue is $3.1B. |
| What is the current revenue growth of Globus Medical? | Globus Medical revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Globus Medical? | Current revenue multiple of Globus Medical is 2.9x. |
| What is the current EBITDA of Globus Medical? | Globus Medical's last 12 months EBITDA is $1.1B. |
| What is Globus Medical's EBITDA margin? | Globus Medical's last 12 months EBITDA margin is 34%. |
| What is the current EV/EBITDA multiple of Globus Medical? | Current EBITDA multiple of Globus Medical is 8.4x. |
| What is the current FCF of Globus Medical? | Globus Medical's last 12 months FCF is $657M. |
| What is Globus Medical's FCF margin? | Globus Medical's last 12 months FCF margin is 21%. |
| What is the current EV/FCF multiple of Globus Medical? | Current FCF multiple of Globus Medical is 13.5x. |
| How many companies Globus Medical has acquired to date? | As of November 2026, Globus Medical has acquired 12 companies. |
| What was the largest acquisition by Globus Medical? | $3.1B acquisition of NuVasive on 9th February 2023 was the largest M&A Globus Medical has done to date. |
| What companies Globus Medical acquired? | Globus Medical acquired NuVasive, Nevro, Alphatec Spine (international distribution unit), Branch Medical Group, Transplant Technologies of Texas, KB Medical, StelKast, Synoste Oy, Surgimap, Synaptive Medical, and 2 other companies. |
| In how many companies Globus Medical has invested to date? | Globus Medical hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Globus Medical
Lists including Globus Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




